Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety Study. [PDF]
Rubinstein A +10 more
europepmc +1 more source
The relative frequency of primary immunodeficiency diseases in pediatric patients with recurrent sinusitis and otitis media [PDF]
Shideh Asar +4 more
openalex +1 more source
Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases: A Single Center Experience. [PDF]
Kwon WK +12 more
europepmc +1 more source
Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases [PDF]
Gillian L. Dornan, John E. Burke
openalex +1 more source
Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label study. [PDF]
Kanegane H +16 more
europepmc +1 more source
Primary immunodeficiency diseases: when we should suspect [PDF]
Simara Zabulon de Albuquerque Bastos +7 more
openalex +1 more source
Safety of tunneled central venous catheters in pediatric hematopoietic stem cell recipients with severe primary immunodeficiency diseases. [PDF]
Martynov I +4 more
europepmc +1 more source
Primary immunodeficiency diseases, inflammation and mitochondrial dysfunction
Salvatore Nesci +3 more
openalex +1 more source
Current Perspectives and Challenges of Primary Immunodeficiency Diseases in Malaysia
Intan Juliana Abd Hamid +2 more
openalex +2 more sources

